
Chief Executive Officer

Stella leads finance and business operations at DCT, driving the strategic initiatives and operational execution required for organisational sustainability. With multi-industry experience spanning healthcare, social enterprise, agriculture, and technology startups, she specialises in financial transformation and implementing best-practice business systems and processes within high-growth environments. Stella partners closely with the CEO and Board to manage critical funding, non-clinical regulatory compliance, and reporting obligations to the University of Melbourne. Her focus on robust financial controls and risk management provides the corporate business infrastructure and fiscal framework that enable DCT’s clinical teams to deliver world-class trial outcomes.
A skills-based board combines comprehensive experience in academic research, financial strategy, commercial development and biotechnology & pharmaceutical industries. Along with the specialised leadership team, this expertise drives Doherty Clinical Trials Ltd unique capabilities.